TY - JOUR
T1 - The Future Role of the United States in Global Health
T2 - Emphasis on Cardiovascular Disease
AU - on behalf of the
AU - Committee on Global Health and the Future of the United States: A Report of the National Academies of Sciences, Engineering and Medicine
AU - Committee on Global Health and the Future of the United States: A Report of the National Academies of Sciences, Engineering and Medicine
AU - Fuster, Valentin
AU - Frazer, Jendayi
AU - Snair, Megan
AU - Vedanthan, Rajesh
AU - Dzau, Victor
AU - Frazer, Jendayi
AU - Abbam, Gisela
AU - Batson, Amie
AU - Burkle, Frederick
AU - Chin, Lynda
AU - Fernald, Lia Haskin
AU - Ferguson, Stephanie
AU - Lamptey, Peter
AU - Laxminarayan, Ramanan
AU - Merson, Michael
AU - Narasimhan, Vasant
AU - Osterholm, Michael
AU - Puyana, Juan Carlos
N1 - Publisher Copyright:
© 2017
PY - 2017/12/26
Y1 - 2017/12/26
N2 - U.S. global health investment has focused on detection, treatment, and eradication of infectious diseases such as tuberculosis, malaria, and human immunodeficiency virus/acquired immunodeficiency syndrome, with significant results. Although efforts should be maintained and expanded to provide ongoing therapy for chronic infectious disease, there is a pressing need to meet the challenge of noncommunicable diseases, which constitute the highest burden of diseases globally. A Committee of the National Academies of Sciences, Engineering, and Medicine has made 14 recommendations that require ongoing commitments to eradication of infectious disease and increase the emphasis on chronic diseases such as cardiovascular disease. These include improving early detection and treatment, mitigating disease risk factors, shifting global health infrastructure to include management of cardiovascular disease, developing global partners and private-public ventures to meet infrastructure and funding challenges, streamlining medical product development and supply, increasing research and development capacity, and addressing gaps in global political and institutional leadership to meet the shifting challenge.
AB - U.S. global health investment has focused on detection, treatment, and eradication of infectious diseases such as tuberculosis, malaria, and human immunodeficiency virus/acquired immunodeficiency syndrome, with significant results. Although efforts should be maintained and expanded to provide ongoing therapy for chronic infectious disease, there is a pressing need to meet the challenge of noncommunicable diseases, which constitute the highest burden of diseases globally. A Committee of the National Academies of Sciences, Engineering, and Medicine has made 14 recommendations that require ongoing commitments to eradication of infectious disease and increase the emphasis on chronic diseases such as cardiovascular disease. These include improving early detection and treatment, mitigating disease risk factors, shifting global health infrastructure to include management of cardiovascular disease, developing global partners and private-public ventures to meet infrastructure and funding challenges, streamlining medical product development and supply, increasing research and development capacity, and addressing gaps in global political and institutional leadership to meet the shifting challenge.
KW - cardiovascular health
KW - global health
KW - noncommunicable diseases
UR - http://www.scopus.com/inward/record.url?scp=85035314566&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85035314566&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2017.11.009
DO - 10.1016/j.jacc.2017.11.009
M3 - Review article
C2 - 29198877
AN - SCOPUS:85035314566
SN - 0735-1097
VL - 70
SP - 3140
EP - 3156
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 25
ER -